Muscular Dystrophies Clinical Trial
— ZRM-CMD-POfficial title:
Self-management Training for Parents With Chronic Muscular Dystrophia
Verified date | August 2019 |
Source | University Children's Hospital, Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The relentless progressive process of muscular dystrophy requires extraordinary medical, physical, and emotional care with severe consequences for caring parents (increased stress and diminished social, psychological and physical well-being). Despite the obvious need of support for parents only few and weak data exist regarding efficiency and efficacy of specific interventions supporting parental resilience and coping strategies. The presenting study aims to fill this gap by evaluating the efficacy of a structured self-management training for parents of children with severe progressive muscular dystrophy compared to parents receiving treatment as usual (TAU). In addition, investigators measure established biomarkers of psychosocial stress, such as pro-inflammatory cytokines, which will be used to monitor physiological changes with assumed significance for parental health.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2019 |
Est. primary completion date | December 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Parents with at least one living child affected by chronic muscular dystrophy Exclusion Criteria: - Dying of a child during intervention and analysis. - Severe/significant psychological disorder (in case of existing psychological support, participation should be agreed/supported by therapist, too) - Recent or concomitant self-management training |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Children's Hospital, Zurich | University of Zurich |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Action Orientation Questionnaire (HAKEMP) | Kuhl and co-workers introduced a special questionnaire (HAKEMP) to assess the tendency of people in concrete situations to revert to an action-oriented or state-oriented condition in 24 items. | 1 1/2 year with control group | |
Primary | Self-efficacy: Thought control of action (SWE) | Quantify improved parental resilience and coping strategies facing chronic stress. Questionnaire developed by Jerusalem and Schwarzer, 1981, revised 1999 to test general self-efficacy in 10 items. | 1 1/2 year with control group | |
Primary | Change in Experiencing and Behaviour post-intervention (VEV) | VEV is a questionnaire developed by Ziele and Kopf-Mehnert, 1978 to test post-intervention change in experiencing and behavior along with a retrospective life-event checklist and a self-rating questionnaire in 42 items. Other than previous questionnaires VEV will be applied only after intervention. | 1 1/2 year with control group | |
Secondary | Number of Participants With Sum of Abnormal Laboratory Values Concerning Biomarkers of psychosocial stress | Significant lower levels of biomarkers of psychosocial stress, i.e. pro-inflammatory cytokines, which can be used to monitor physiological changes with assumed significance for parental health: C-reactive Protein (hsCRP), Tumor-Necrose-Factor alpha (TNFa), Interleukin (IL)-1ß, IL-6, und Interferon Gamma (IFN?). Items will be aggregated as a numerical factor which shows the difference of a measured value from a reference value . Abnormal laboratory values therefore will be used as a sum. | 1 1/2 year with control group |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01480245 -
Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
|
Phase 3 | |
Completed |
NCT01153932 -
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT00027391 -
Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
|
N/A | |
Recruiting |
NCT04392518 -
Telerehabilitation in Proximal Muscle Weakness
|
N/A | |
Completed |
NCT03851107 -
The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities
|
N/A | |
Completed |
NCT01462292 -
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
|
Phase 2 | |
Recruiting |
NCT06094205 -
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
|
N/A | |
Recruiting |
NCT05724173 -
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
|
N/A | |
Recruiting |
NCT03698149 -
ECoG BMI for Motor and Speech Control
|
N/A | |
Active, not recruiting |
NCT03811301 -
[BrainConnexion] - Neurodevice Phase I Trial
|
N/A | |
Completed |
NCT05881122 -
Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability
|
N/A | |
Completed |
NCT04154098 -
Evaluation of a Textile Scapula Orthosis
|
N/A | |
Recruiting |
NCT05409079 -
Schulze Muscular Dystrophy Ability Clinical Study
|
N/A | |
Enrolling by invitation |
NCT04009408 -
Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders
|
N/A | |
Active, not recruiting |
NCT00674843 -
The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies
|
Phase 1 | |
Recruiting |
NCT02109692 -
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
|
N/A | |
Active, not recruiting |
NCT04045158 -
Diaphragm Ultrasound in Neuromuscular Disorders
|
||
Not yet recruiting |
NCT03508583 -
Turkish Version of The Measure of Processes of Care (MPOC)
|
||
Terminated |
NCT01803412 -
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
|
Phase 3 | |
Completed |
NCT03406780 -
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2 |